Mice treated with combination anti-CTLA-4 and anti-PD-1 present with elevated levels of IL-12 in tumour free tissues, an activated MHCIIhigh phenotype of KCs and an increase in liver neutrophils. This evidence concerns the gene CTLA4 and neoplasm.